Drug
BEAM regimen clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 1996 (1)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1998 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
University of Nebraska (2) · Fondazione Italiana Linfomi - ETS (1) · Lymphoma Study Association (1) · National Cancer Institute (NCI) (1) · Heidelberg University (1)
Often tested with
Tested in the same studies.
Rituximab (1) · Ibritumomab tiuxetan (1) · Antineoplastic Agents (1)
Studies
Open first, then newest update. How each study uses BEAM regimen is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)CompletedPhase 3Fondazione Italiana Linfomi - ETSNCT01827605Written as BEAM
- Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's LymphomaCompletedPhase 1University of NebraskaNCT00574509Written as BEAM
- Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent LymphomaCompletedPhase 1/2University of NebraskaNCT00572013Written as BEAM
- Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's LymphomaTerminatedPhase 1/2National Cancer Institute (NCI)NCT01468311Written as BEAM
- Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-LymphomaStatus unknownPhase 2Heidelberg UniversityNCT00946374Written as High-dose BEAM plus autologous SCT
- Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell LymphomaCompletedPhase 2Lymphoma Study AssociationNCT00138086Written as Zevalin plus BEAM
Given in every arm · 1 — BEAM regimen is usual care beside what is tested
As the comparator · 4 — what is tested is compared with BEAM regimen
- Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCLNot yet recruitingPhase 2Ruijin HospitalNCT06652165Written as BEAM
- Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC PositiveNot yet recruitingPhase 2Ruijin HospitalNCT06652139Written as BEAM regimen
- Modified BEAM Regimen for T Cell Lymphoma Underwent ASCTNot yet recruitingNot applicableFirst Affiliated Hospital Xi'an Jiaotong UniversityNCT05814718Written as BEAM
- A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)CompletedPhase 2Insel Gruppe AG, University Hospital BernNCT02278796Written as BEAM